Patent foramen ovale closure or medical therapy for secondary prevention of cryptogenic stroke: An update meta-analysis of randomized controlled trials

Medicine
Yingxu MaQiming Liu

Abstract

It was under debate whether cryptogenic stroke patients benefited from patent foramen ovale (PFO) closure. We sought to determine secondary prevention strategy in these patients. Scientific databases were searched for randomized controlled trials enrolling cryptogenic stroke patients with PFO who underwent PFO closure or medical therapy. The random-effect model was used to analyze the outcomes. We identified 6 trials enrolling 3630 participants in this meta-analysis. When compared with medical therapy, PFO closure reduced risks of recurrent stroke (risk ratio [RR] 0.52, 95% confidence interval [CI] 0.29-0.93) and composite of stroke and transient ischemic attack (TIA) (RR 0.60, 95% CI 0.46-0.80). And no differences in all-cause death (RR 0.80, 95% CI 0.37-1.72) and cardiovascular death (RR 1.47, 95% CI 0.36-5.94) between 2 groups were observed. The risks of major bleeding (RR 0.96, 95% CI 0.47-1.96) and any serious adverse event (RR 1.03, 95% CI 0.92-1.16) did not differ between 2 groups. Yet, PFO closure increased risk of atrial fibrillation (RR 4.25, 95% CI 2.10-8.60). PFO closure, as compared with medical therapy, was associated with decreased risk of recurrent stroke and increased risk of atrial fibrillation in cryptogenic ...Continue Reading

References

Apr 1, 1989·Annals of Neurology·R L SaccoP A Wolf
Jun 5, 2002·Circulation·Shunichi HommaUNKNOWN PFO in Cryptogenic Stroke Study (PICSS) Investigators
Aug 18, 2004·Journal of the American College of Cardiology·Stephan WindeckerBernhard Meier
Apr 22, 2005·Journal of Thrombosis and Haemostasis : JTH·S SchulmanUNKNOWN Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on T
Apr 30, 2005·International Journal of Cardiology·Herwig Walter SchuchlenzReinhold Schmidt
Jan 18, 2006·Journal of the American College of Cardiology·Irene MeissnerYoram Agmon
Feb 20, 2007·Journal of the American College of Cardiology·Marco R Di TullioShunichi Homma
Nov 30, 2007·The New England Journal of Medicine·Michael HandkeAnnette Geibel
Mar 16, 2012·The New England Journal of Medicine·Anthony J FurlanUNKNOWN CLOSURE I Investigators
Mar 22, 2013·The New England Journal of Medicine·Bernhard MeierUNKNOWN PC Trial Investigators
Mar 22, 2013·The New England Journal of Medicine·John D CarrollUNKNOWN RESPECT Investigators
May 3, 2014·Stroke; a Journal of Cerebral Circulation·Walter N KernanUNKNOWN American Heart Association Stroke Council, Council on Cardiovascular and Stroke Nursing, Council on Clinical Cardiology, and
Feb 27, 2016·Journal of the American College of Cardiology·David M KentDavid E Thaler
Sep 14, 2017·The New England Journal of Medicine·Lars SøndergaardUNKNOWN Gore REDUCE Clinical Study Investigators
Sep 14, 2017·The New England Journal of Medicine·Jeffrey L SaverUNKNOWN RESPECT Investigators
Sep 14, 2017·The New England Journal of Medicine·Jean-Louis MasUNKNOWN CLOSE Investigators
Oct 27, 2017·Stroke; a Journal of Cerebral Circulation·David GaistLuis Alberto García Rodríguez
Mar 17, 2018·Journal of the American College of Cardiology·Pil Hyung LeeSeung-Jung Park

❮ Previous
Next ❯

Software Mentioned

RESPECT
Review Manager
Cochrane Collaboration Tool
Stata

Related Concepts

Related Feeds

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.